I don't think so. This is the end of uncertainty on the HGSI deal. So, all the synergies can now begin to work, the cost of the acquisition won't go any higher, which was a fear, Benlysta finally has the backing it needs to succeed, including GSK's marketing clout, etc., etc. -this all spells an upward trending GSK share price. The stock was headed north before the takeover attempt was announced and plumetted on the announcement --that was when the short would have worked. Not now. Besides, with the antidilutive effect of a $3.9Billion buyback of a market cap of $12Billion - that's 1/3 removal of shares from the market at today's price... Looks like a long to me, so I am.